Migraine in the elderly: A review

Cephalalgia

Volumn 27, Issue 2, 2007, Pages 97-106

  Haan, J ^a,b   Hollander, J ^b   Ferrari, M D ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RIJNLAND HOSPITAL   (Netherlands)

Author keywords

Ageing; Comorbidity; Migraine

Indexed keywords

ACETYLSALICYLIC ACID; ALMOTRIPTAN; ANALGESIC AGENT; ANTICOAGULANT AGENT; ANTIEMETIC AGENT; ANTIHYPERTENSIVE AGENT; BARBITURIC ACID DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; CORTICOSTEROID; CYCLOSPORIN; CYTOCHROME P450 INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERGOTAMINE; LITHIUM; METHOTREXATE; METOCLOPRAMIDE; MONOAMINE OXIDASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; OPIATE; PARACETAMOL; PHENYTOIN; PROPRANOLOL; PROTON PUMP INHIBITOR; RIZATRIPTAN; SEROTONIN UPTAKE INHIBITOR; TACROLIMUS; TRIPTAN DERIVATIVE; UNINDEXED DRUG;

AGE DISTRIBUTION; AGING; CARDIOVASCULAR RISK; CLINICAL FEATURE; COGNITIVE DEFECT; COMORBIDITY; CONSTIPATION; CORONARY ARTERY CONSTRICTION; DEPRESSION; DIGESTIVE SYSTEM PERFORATION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG SAFETY; EPILEPSY; EXTRAPYRAMIDAL SYMPTOM; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTENSION; HYPOTENSION; KIDNEY FAILURE; MIGRAINE; MIGRAINE AURA; PATHOPHYSIOLOGY; PEPTIC ULCER; PREVALENCE; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEDATION; SEROTONIN SYNDROME; SEX RATIO; SIDE EFFECT; STOMACH HEMORRHAGE; STOMACH ULCER; SYNCOPE; TRANSFORMED MIGRAINE; TREATMENT OUTCOME; URINE RETENTION; VERTIGO;

AGED; AGED, 80 AND OVER; COMORBIDITY; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PROGNOSIS;

EID: 33846483819     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2006.01250.x     Document Type: Review

References (77)

1. Goadsby PJ, Lipton RB, Ferrari MD. Migraine. Current understanding and treatment. N Engl J Med 2002; 346:257-70.
2. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 1992; 267:64-9.
3. Lipton RB, Pfeffer D, Newman LC, Solomon S. Headaches in the elderly. J Pain Sympt Manag 1993; 8:87-97.
4. Edmeads J. Headaches in older people. How are they different in this age-group? Postgrad Med 1997; 101:91-100.
5. Gladstone JP, Eross EJ, Dodick DW. Migraine in special populations. Treatment strategies for children and adolescents, pregnant women, and the elderly. Postgrad Med 2004; 115:39-50.
6. Lisotto C, Mainardi F, Maggioni F, Dainese F, Zanchin G. Headache in the elderly: a clinical study. J Headache Pain 2004; 5:36-41.
7. Cologno D, Torelli P, Manzoni CG. Migraine with aura. A review of 81 patients at 10-20 years' follow-up. Cephalalgia 1998; 18:690-6.
8. Eriksen MK, Thomsen LL, Russell MB. Prognosis of migraine with aura. Cephalalgia 2004; 24:18-22.
9. Lyngberg AC, Rasmussen BK, Jorgensen T, Jensen R. Prognosis of migraine and tension-type headache. A population-based follow-up study. Neurology 2005; 65:580-5.
10. Nachit-Ouinekh F, Dartigues JF, Chrystosome V, Henry P, Sourgen C, El Hasnaoui A. Evolution of migraine after a 10-year follow-up. Headache 2005; 45:1280-7.
11. Rasmussen BK, Lipton RB. Prognosis of migraines. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA, editors. The headaches, 3rd edn. Philadelphia: Lippincott Williams & Wilkins 2006:429-31.
12. Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population-based cohort. The GEM Study. Neurology 1999; 53:537-42.
13. Mattsson P, Svardsudd K, Lundberg PO, Westerberg CE. The prevalence of migraine in women aged 40-74 years. A population-based study. Cephalalgia 2000; 20:893-9.
14. Rasmussen BK, Olesen J. Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia 1992; 12:221-8.
15. O'Brien B, Goeree R, Streiner D. Prevalence of migraine headache in Canada: a population-based survey. Int J Epidemiol 1994; 23:1020-6.
16. Henry P, Michel P, Brochet B, Dartigues JF, Tison S, Salamon R. A nationwide survey of migraine in France: prevalence and clinical features in adults. Cephalalgia 1992; 12:229-37.
17. Wang SJ, Liu HC, Fuh JL, Liu CY, Lin KP, Chen HM et al. Prevalence of headaches in a Chinese elderly population in Kinmen: age and gender effect and cross-cultural comparisons. Neurology 1997; 49:195-200.
18. Francheschi M, Colombo B, Rossi P, Canal N. Headache in a population-based elderly cohort. An ancillary study to the Italian longitudinal study of aging (ILS). Headache 1997; 37:79-82.
19. Camarda R, Monastero R. Prevalence of primary headaches in Italian elderly: preliminary data from the Zabut aging project. Neurol Sci 2003; 24:S122-S124.
20. Prencipe M, Casini AR, Ferretti C, Santini M, Pezzella F, Scaldaferri N, Culasso F. Prevalence of headache in an elderly population. Attack frequency, disability, and use of medication. J Neurol Neurosurg Psychiatry 2006; 70:377-81.
21. Aring CD. Late-life migraine. Arch Neurol 1991; 48:1174-7.
22. Martins KM, Bordini CA, Bigal ME, Speciali JG. Migraine in the elderly: a comparison with migraine in young adults. Headache 2006; 46:312-6.
23. Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB. Chronic migraine is an earlier stage of transformed migraine in adults. Neurology 2005; 65:1556-61.
24. Dodick DW. Chronic daily headache. N Engl J Med 2006; 354:158-65.
25. Fisher CM. Late-life migraine accompaniments as a cause of unexplained transient ischemic attacks. Can J Neurol Sci 1980; 7:9-17.
26. Fisher CM. Late-life migraine accompaniments. Further experience. Stroke 1986; 17:1033-42.
27. Wijman CAC, Wolf PA, Kase CS, Kelly-Hayes M, Beiser AS. Migrainous visual accompaniments are not rare in late life. The Framingham study. Stroke 1998; 29:1539-43.
28. Pascual J, Berciano J. Experience in the diagnosis of headaches that start in elderly people. J Neurol Neurosurg Psychiatry 1994; 57:1255-7.
29. Bruining K. New onset migraine in the elderly. Headache 2002; 42:946-7.
30. Biondi DM, Saper JR. Geriatric headache. How to make the diagnosis and manage the pain. Geriatrics 2000; 55:40-50.
31. Cull RE. Investigation of late-onset migraine. Scot Med J 1995; 40:50-2.
32. McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev 2004; 56:163-84.
33. Scher AI, Bigal ME, Lipton RB. Comorbidity of migraine. Curr Opin Neurol 2005; 18:305-10.
34. Bousser MG, Welch KMA. Relation between migraine and stroke. Lancet Neurol 2005; 4:533-42.
35. Mosek A, Marom R, Korczyn AD, Bornstein N. A history of migraine is not a risk factor to develop an ischemic stroke in the elderly. Headache 2001; 41:399-401.
36. Kurth T, Slomke MA, Kase CS, Cook NR, Lee IM, Gaciano JM et al. Migraine, headache, and the risk of stroke in women. A prospective study. Neurology 2005; 64:1020-6.
37. Tzourio C, Gagniere B, El Amrani M, Alperovich A, Bousser MG. Relationship between migraine, blood pressure and carotid thickness. A population-based study in the elderly. Cephalalgia 2003; 23:914-20.
38. Gudmundsson LS, Thorgeirsson G, Sigfusson N, Sigvaldason H, Johannsson M. Migraine patients have lower systolic but higher diastolic blood pressure compared with controls in a population-based study of 21537 subjects. The Reykjavik study. Cephalalgia 2006; 26:436-44.
39. Scher AI, Terwindt GM, Picavet HSJ, Verschuren WMM, Ferrari MD, Launer LJ. Cardiovascular risk factors and migraine. The GEM population-based study. Neurology 2005; 64:614-20.
40. Stang PE, Carson AP, Rose KM, Mo J, Ephross SA, Shahar E, Szklo M. Headache, cerebrovascular symptoms, and stroke. The atherosclerosis risk in communities study. Neurology 2005; 64:1573-7.
41. Tietjen GE. The relationsip of migraine and stroke. Neuroepidemiology 2000; 19:13-9.
42. Breslau N, Lipton RB, Stewart WF, Schultz LR, Welch KMA. Comorbidity of migraine and depression. Investigating potential etiology and prognosis. Neurology 2003; 60:1308-12.
43. Wang SJ, Liu HC, Fuh JL, Liu CY, Wang PN, Lu SR. Comorbidity of headaches and depression in the elderly. Pain 1999; 82:239-43.
44. Mattsson P, Ekselius L. Migraine, major depression, panic disorder, and personality traits in women aged 40-74 years: a population-based study. Cephalalgia 2002; 22:543-51.
45. Kruit MC, van Buchem MA, Hofman PA, Bakker JT, Terwindt GM, Ferrari MD, Launer LJ. Migraine as a risk factor for subclinical brain lesions. JAMA 2004; 291:427-34.
46. Jelicic M, van Boxtel MPJ, Houx PJ, Jolles J. Does migraine headache affect cognitive function in the elderly? Report from the Maastricht aging study (MAAS). Headache 2000; 40:715-9.
47. Pearson AJ, Chronicle EP, Maylor EA, Bruce LAM. Cognitive function is not impaired in people with a long history of migraine: a blinded study. Cephalalgia 2006; 26:74-80.
48. Crevits L, Bosman T. Migraine-related vertigo. Towards a distinctive entity. Clin Neurol Neurosurg 2005; 107:82-7.
49. Radtke A, Lempert T, Gresty MA, Brookes GB, Bronstein AM, Neuhauser H. Migraine and Meniere's disease. Is there a link? Neurology 2002; 59:1700-4.
50. Marks DA, Ehrenberg BL. Migraine-related seizures in adults with epilepsy, with EEG correlation. Neurology 1993; 43:2476-83.
51. Ottman R, Lipton RB. Comorbidity of migraine and epilepsy. Neurology 1994; 44:2105-10.
52. Haut SR, Bigal ME, Lipton RB. Chronic disorders with episodic manifestations: focus on epilepsy and migraine. Lancet Neurol 2006; 5:148-57.
53. Chutka DS, Takahashi PY, Hoel RW. Inappropriate medications for elderly patients. Mayo Clin Proc 2004; 79:122-39.
54. Landy SH, Lobo BL. Migraine treatment throughout the lifecycle. Expert Rev Neurotherapeutics 2005; 5:343-53.
55. Gloth FM. Pain management in older adults: prevention and treatment. J Am Geriatr Soc 2001; 49:188-99.
56. AGS panel on persistent pain in older persons. The management of persistent pain in older persons. J Am Geriatr Soc 2002; 50:S205-S224.
57. Burris JE. Pharmacologic approaches to geriatric pain management. Arch Phys Med Rehabil 2004; 85 (Suppl. 3):S45-S49.
58. Tfelt-Hansen P, Saxena PR, Dahlof C, Pascual J, Lainez M, Henry P et al. Ergotamine in the acute treatment of migraine. A review and European consensus. Brain 2000; 123:9-18.
59. Hall GC, Brown MM, Mo J, MacRae KD. Triptans in migraine. The risk of stroke, cardiovascular disease, and death in practice. Neurology 2004; 62:563-8.
60. Musson DG, Birk KL, Panebianco DL, Gagliano KD, Rogers JD, Goldberg MR. Pharmacokinetics of rizatriptan in healthy elderly subjects. Int J Clin Pharmacol Ther 2001; 39:447-52.
61. Peck RW, Seaber EJ, Dixon RM, Layton GR, Weatherley BC, Jackson SH et al. The pharmacodynamics and pharmacokinetics of the 5HT1B/1D-agonist zolmitriptan in healthy young and elderly men and women. Clin Pharmacol Ther 1998; 63:342-53.
62. Loder E, Biondi D. General principles of migraine management. The changing role of prevention. Headache 2005; 45 (Suppl. 1):S33-S47.
63. Rahimtoola H, Buurma H, Tijssen CC, Leufkens HG, Egberts ACG. Migraine prophylactic medication usage in the Netherlands. Cephalalgia 2003; 23:293-301.
64. Inouye SK. Delirium in older persons. N Engl J Med 2006; 354:1157-65.
65. Edmeads JG, Wang SJ. Headaches in the elderly. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA, editors. The headaches, 3rd edn. Philadelphia: Lippincott Williams & Wilkins 2006:1105-10.
66. Punay NC, Couch JR. Antidepressants in the treatment of migraine headache. Curr Pain Headache Rep 2003; 7:51-4.
67. Chronicle E, Mulleners W. Anticonvulsant drugs for migraine prophylaxis. The Cochrane database of systematic reviews. 2004; 3:1-35.
68. Arroyo S, Kramer G. Treating epilepsy in the elderly. Drug Safety 2001; 24:991-1015.
69. Brodie MJ, Kwan P. Epilepsy in elderly people. BMJ 2005; 331:1317-22.
70. Groselj J, Guerrini R, Van Oene J, Lahaye M, Schreiner A, Schwalen S. Experience with topiramate monotherapy in elderly patients with recent onset epilepsy. Acta Neurol Scand 2005; 112:144-50.
71. Schrader H, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomized, placebo controlled, crossover study. BMJ 2001; 322:1-5.
72. Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with an angiotensin II receptor blocker. A randomized controlled trial. JAMA 2003; 289:65-9.
73. Owada K. Efficacy of candesartan in the treatment of migraine in hypertensive patients. Hypertens Res 2004; 27:441-6.
74. Schwartz JB. Calcium antagonists in the elderly. A risk-benefit analysis. Drugs Aging 1996; 9:24-36.
75. Opie LH. Calcium channel blockers for hypertension. Dissecting the evidence for adverse events. Am J Hypertens 1997; 10:565-77.
76. Hansten PD, Horn JR. The top 100 drug interactions: a guide to patient management. Edmonds, WA: H & H Publications 2001:1-163.
77. Ferrari A, Sternieri E, Ferraris E, Bertolini A. Emerging problems in the pharmacology of migraine: interactions between triptans and drugs for prophylaxis. Pharmacol Res 2003; 48:1-9.